Good point that an expectation of market decline h

Good point that an expectation of market decline has occurred rather than an actual market decline, given that CYDY will sell every vial they can produce as soon as they are approved for covid.

So let's see, 1000 covid deaths per day in US, probably increasing to around 2000 per day by February.

If indeed CYDY does have 300,000 Samsung vials on hand, that is enough to treat 75,000 patients.

Probably for each death there are 5 other hospitalized patients who are potential patients.

So that's 10,000 possible LL patients every day if the death rate climbs to 2000 per day in the US alone.

So probably true that a covid approval for LL sells out every vial that CYDY can produce in the forseeable future.

On the other hand, if covid is stopped by an effective vaccine, the ramp down of covid cases could be very fast.

Did I see than Pfizer/Biontech would have 50 million doses available in the US by Jan 1? Does that mean Pfizer could dose 25 million people by Feb 1 (two doses four weeks apart)?

If Pfizer is able to fully dose 50 million high risk individuals by Feb 1, that will take a bite, potentially a large bite, out of deaths and hospitalizations because the high risk indidviduals are the people who end up hospitalized?????